Isolated ultrafiltration in cardiogenic pulmonary edema

Area of Science:

• Cardiology
• Nephrology
• Critical Care Medicine

Background:

• Acute pulmonary edema (APE) in severe heart disease (NYHA class IV) often requires intensive treatment.
• Drug-refractory APE presents a significant clinical challenge, potentially necessitating mechanical ventilation.
• Overhydration and pulmonary congestion are key pathophysiological features of APE.

Purpose of the Study:

• To evaluate the efficacy and safety of polysulfone membrane ultrafiltration (UF) in patients with drug-refractory cardiogenic pulmonary edema.
• To assess the impact of UF on gas exchange, hemodynamics, and radiographic findings.
• To determine if UF can serve as an alternative to mechanical ventilation.

Main Methods:

• Twenty patients with severe heart disease and APE unresponsive to conventional therapy underwent veno-venous polysulfone membrane ultrafiltration.
• Hemodynamic parameters, including cardiac output and intrapulmonary shunt fraction (Qsp/Qt), were measured before and after UF.
• Chest X-rays were performed to assess pulmonary vascular congestion and alveolar edema.

Main Results:

• Ultrafiltration significantly reduced the intrapulmonary shunt fraction (Qsp/Qt) by 58%.
• Radiographic evidence showed clearing of alveolar edema and pulmonary venous congestion.
• Clinical improvement was observed, with no need for mechanical ventilation, and no significant adverse hemodynamic changes or alterations in plasma osmolarity.

Conclusions:

• Polysulfone membrane ultrafiltration is an effective treatment for acute pulmonary edema refractory to drug therapy.
• UF offers a valuable alternative to mechanical ventilation for managing severe pulmonary congestion.
• Short-term fluid removal via UF can alleviate excessive extravascular lung water without compromising circulatory stability.